Pfizer Lipitor Profitability Among Items In Dispute In Warner-Lambert Bid
Executive Summary
The effect of the Lipitor co-promotion on Pfizer's earnings ranges from break-even to one quarter of profits, depending on which partner in the agreement is doing the accounting.
You may also be interested in...
Pfizer/Warner Pro Forma Accounting Shows 1.5% Margin Benefit From Lipitor
Pfizer/Warner-Lambert's pro forma operating margins will be 1.5 percentage points closer to the Pfizer level after the elimination of double-counting of Lipitor sales.
Pfizer/Warner Pro Forma Accounting Shows 1.5% Margin Benefit From Lipitor
Pfizer/Warner-Lambert's pro forma operating margins will be 1.5 percentage points closer to the Pfizer level after the elimination of double-counting of Lipitor sales.
Pfizer/Warner-Lambert Savings Would Be Akin To Acquiring Another Zoloft
A Pfizer/Warner-Lambert combination would achieve $1.6 bil. in cost savings by 2002, Pfizer declared.